Samina Asad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samina Asad has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Magnus Nordenskjöld
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden
3 shared publications - Fulya Taylan
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Marten C. G. Winge
Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
2 shared publications A Montes
Karolinska Inst, Dept Med Solna, Dermatol Unit, SE-17176 Stockholm, Sweden
1 shared publicationC Wahlgren
Karolinska Inst, Dept Med Solna, Dermatol Unit, SE-17176 Stockholm, Sweden
1 shared publicationC.‐F. Wahlgren
Dermatology Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden
1 shared publication
Latest Publications
- Open Access
- 1 January 2018
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 99 (1) , 101-102
Evaluation of Single Nucleotide Variants in Ethiopian Patients with Atopic Dermatitis
Is missing (Short communication)...
- 1 January 2018
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 99 (1) , 101-102
Open AccessEvaluation of Single Nucleotide Variants in Ethiopian Patients with Atopic Dermatitis
Is missing (Short communication)...
- 10 March 2017
- Published by Wiley in Pediatric Dermatology
- Vol. 34 (3) , e140-e141
Intragenic Copy Number Variation in the Filaggrin Gene in Ethiopian Patients with Atopic Dermatitis
Genetic variants in filaggrin (FLG) involving truncating mutations or intragenic copy number variation are strongly associated with the risk of developing atopic dermatitis (AD) in European and Asian populations. Few loss‐of‐function mutations have been identified in Africans, although an association between FLG copy number variation and AD severity in a small African American cohort has been proposed. We studied the association between FLG copy number and AD in 132 Ethiopians and found no association between AD severity and FLG copy number, suggesting that other, still unidentified genetic factors are of more importance in predisposing Ethiopians to AD.
- 10 March 2017
- Published by Wiley in Pediatric Dermatology
- Vol. 34 (3) , e140-e141
Intragenic Copy Number Variation in the Filaggrin Gene in Ethiopian Patients with Atopic Dermatitis
Genetic variants in filaggrin (FLG) involving truncating mutations or intragenic copy number variation are strongly associated with the risk of developing atopic dermatitis (AD) in European and Asian populations. Few loss‐of‐function mutations have been identified in Africans, although an association between FLG copy number variation and AD severity in a small African American cohort has been proposed. We studied the association between FLG copy number and AD in 132 Ethiopians and found no association between AD severity and FLG copy number, suggesting that other, still unidentified genetic factors are of more importance in predisposing Ethiopians to AD.
- 31 August 2016
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 30 (11) , 1939-1941
The tight junction gene Claudin‐1 is associated with atopic dermatitis among Ethiopians
Background: The strong association between epidermal barrier gene variants and Atopic Dermatitis (AD) highlights that impaired skin barrier is a key feature in the pathogenesis of AD. Although the filaggrin (FLG) gene is the major AD risk gene in European and Asian populations, disease‐associated variants remain elusive in African populations.Objective: A previous study has reported that variants in the tight junction gene CLDN1 have been associated with AD susceptibility and disease severity in African‐Americans. Our aim was therefore to investigate the association of CLDN1 with AD in the Ethiopian population.Methods: To investigate how CLDN1 variants may be involved in increasing the risk of AD in the Ethiopian population, we analysed whole exome sequencing (WES) data for all exons in CLDN1, and in addition, assayed four SNPs (rs17501010, rs9290927, rs9290929 and rs893051) which had previously showed association in African‐American AD patients.Results: No damaging variants were detected through WES in 22 Ethiopian samples. Genotyping of disease‐associated CLDN1 SNPs in Ethiopian cases and control material showed no overall association. However, significant association was seen for rs893051 in patients who developed AD before the age of 5 years (P < 0.03). Conclusion: Taken together, we demonstrate that tight junction genes and, in particular, CLDN1 rather than variants in FLG may be involved in the susceptibility of AD in the Ethiopian population.
- 31 August 2016
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 30 (11) , 1939-1941
The tight junction gene Claudin‐1 is associated with atopic dermatitis among Ethiopians
Background: The strong association between epidermal barrier gene variants and Atopic Dermatitis (AD) highlights that impaired skin barrier is a key feature in the pathogenesis of AD. Although the filaggrin (FLG) gene is the major AD risk gene in European and Asian populations, disease‐associated variants remain elusive in African populations.Objective: A previous study has reported that variants in the tight junction gene CLDN1 have been associated with AD susceptibility and disease severity in African‐Americans. Our aim was therefore to investigate the association of CLDN1 with AD in the Ethiopian population.Methods: To investigate how CLDN1 variants may be involved in increasing the risk of AD in the Ethiopian population, we analysed whole exome sequencing (WES) data for all exons in CLDN1, and in addition, assayed four SNPs (rs17501010, rs9290927, rs9290929 and rs893051) which had previously showed association in African‐American AD patients.Results: No damaging variants were detected through WES in 22 Ethiopian samples. Genotyping of disease‐associated CLDN1 SNPs in Ethiopian cases and control material showed no overall association. However, significant association was seen for rs893051 in patients who developed AD before the age of 5 years (P < 0.03). Conclusion: Taken together, we demonstrate that tight junction genes and, in particular, CLDN1 rather than variants in FLG may be involved in the susceptibility of AD in the Ethiopian population.